Impact of progestins on estrogen-induced neuroprotection: Synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate

Endocrinology

Volumn 143, Issue 1, 2002, Pages 205-212

  Nilsen, Jon ^a   Brinton, Roberta Diaz ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

19 NORPROGESTERONE; ESTRADIOL; ESTROGEN; GESTAGEN; GLUTAMIC ACID; MEDROXYPROGESTERONE ACETATE; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE; PROGESTERONE DERIVATIVE; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL DEATH; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; ENZYME ACTIVATION; ESTROGEN THERAPY; HIPPOCAMPUS; HORMONAL REGULATION; HORMONE SUBSTITUTION; INCIDENCE; MENOPAUSE; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0036141071     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.1.8582     Document Type: Article

References (42)

1. Progesterone inhibits the estrogen-induced expression of c-fos messenger ribonucleic acid in the uterus
2. Regulation of progesterone receptor gene expression and growth in the rat uterus: Modulation of estrogen action by progesterone and sex steroid hormone antagonist
3. Estrogen action in the reproductive tract of the rhesus monkey during antiprogestin treatment
4. Prevention of endometrial cancer with progestogens
5. Progestins
6. Use of progestogens in postmenopausal women
7. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
8. A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health
9. Estrogen, cognition, and a woman's risk of Alzheimer's disease
10. The female sex hormone oestrogen as a neuroprotectant
11. The estrogen replacement therapy of the Women's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease
12. Putative membrane-bound estrogen receptors possibly stimulate mitogen-activated protein kinase in the rat hippocampus
13. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
14. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways
15. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity, in primary cortical neurons
16. Role of BCL-2 in the survival and function of developing and mature sympathetic neurons
17. Bcl-2 blocks glutamate toxicity in neural cell lines
18. Estradiol up-regulates bcl-2 expression in adult brain neurons
19. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system
20. Modulation of bcl-2 expression: A potential component of estrogen protection in NT2 neurons
21. Estrogen protects primary cortical neurons from glutamate toxicity
22. Progesterone in conjunction with estradiol has neuroprotective effects in an animal model of neurodegeneration
23. Gender influences outcome of brain injury: Progesterone plays a protective role
24. 17beta-estradiol induction of filopodial growth in cultured hippocampal neurons within minutes of exposure
25. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay
26. Increased risk of familial late-onset Alzheimer's disease in women
27. Estrogen replacement therapy in older women: Comparisons between Alzheimer's disease cases and nondemented control subjects
28. Cardiovascular health and disease in women
29. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study
30. Oestrogen replacement therapy and Alzheimer's disease
31. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
32. Estrogen improves psychological function in asymptomatic postmenopausal women
33. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer's type: 7 case reports
34. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women
35. Rapid effects of gonadal steroids upon hypothalamic neuronal membrane ultrastructure
36. The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus
37. Protein kinase C(delta) mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells
38. The proto-oncogene bcl-2 inhibits apoptosis in PC12 cells
39. BCL-2 inhibits death of central neural cells induced by multiple agents
40. Antagonism between estradiol and progestin on bcl-2 expression in breast-cancer cells
41. The postmenopausal estrogen/progestin interventions study: Primary outcomes in adherent women
42. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women: Influence of various progestogens and duration of therapy